Zeria Pharmaceutical Co Ltd 4559.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 04/16/21 JST
2,053.00quote price arrow down-13.00 (-0.63%)
Volume
19,300
52 week range
1,822.00 - 2,309.00

...

Loading . . .
  • Open2,069.00
  • Day High2,073.00
  • Day Low2,052.00
  • Prev Close2,066.00
  • 52 Week High2,309.00
  • 52 Week High Date03/29/21
  • 52 Week Low1,822.00
  • 52 Week Low Date10/28/20

Key Stats

  • Market Cap867M
  • Shares Out45.95M
  • 10 Day Average Volume47,000
  • Dividend34.00
  • Dividend Yield1.66%
  • Beta
  • YTD % Change8

KEY STATS

  • Open2,069.00
  • Day High2,073.00
  • Day Low2,052.00
  • Prev Close2,066.00
  • 52 Week High2,309.00
  • 52 Week High Date03/29/21
  • 52 Week Low1,822.00
  • 52 Week Low Date10/28/20
  • Market Cap867M
  • Shares Out45.95M
  • 10 Day Average Volume47,000
  • Dividend34.00
  • Dividend Yield1.66%
  • Beta
  • YTD % Change8

RATIOS/PROFITABILITY

  • EPS (TTM)81.00
  • P/E (TTM)25.35
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date09/29/2020
  • Div Amount17.00
  • Split Date-
  • Split Factor-

Latest From Zeria Pharmaceutical Co Ltd

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Zeria Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the development of ethical drug business, consumer healthcare business and other business. The Company operates in two business segments. The Ethical Drug segment is engaged in the research, development, manufacture and sale of ethical drugs. The Consumer Healthcare segment is engaged in the manufacture, purchase and sale of over-the-counter (OTC) drugs, health foods, quasi drugs and cosmetics related to...
Sachiaki Ibe
Chairman
Mitsuhiro Ibe
President
Address
10-11, Nihombashi Kobuna-cho
Chuo-ku, TKY
103-8351
Japan